Issue Date: Sep 30, 2010
On July 15, 1962, a Washington Post story, ‘Heroine of FDA keeps bad drug off market,’ shocked Americans. The heroine in question was Frances Oldham Kelsey. She had joined the US Food and Drug Administration two years earlier as a drug application investigator. With her expertise in pharmacology, she was the obvious choice to test the veracity of an application for a “harmless” sedative that was already being sold in 46 countries. The drug, Kevadon, was one of the trade names of thalidomide.
Illegal salt making threatens Sambhar Lake’s ecology
How a township has set high standard for eco-friendly living
Good job bringing this to light. People won't realise how huge the problem is and municipalities are woefully ill equipped to...
Agreed; mining can never be sustainable, but then how do you get the metals to make all the things you need in the course of...
Very good piece.